Natco Pharma plans to launch 8-10 branded formulations during FY18

05 Jun 2017 Evaluate

In a bid to achieve 20% growth year-on-year, Natco Pharma is planning to launch around 8-10 new products in domestic branded formulations segment during FY18. The Hyderabad-based drug firm is also planning to maintain its leadership position in oncology and gastro hepatology segment during the year as part of its short-term growth plan.

Moreover, the company is looking at gaining traction in the newly launched cardiology and diabetology (CnD) division. The company is also planning to expand its Hepatitis-C product portfolio during the year.

 

Natco Pharma Share Price

889.05 -14.50 (-1.60%)
01-Jan-2026 09:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1711.50
Dr. Reddys Lab 1252.10
Cipla 1500.45
Zydus Lifesciences 907.95
Lupin 2092.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×